Research & Development: Page 45
-
PharmaVoice Team/PharmaVoice
The Future of Healthcare is Wearable
EHR is connecting our healthcare, the Internet of things is connecting our world, and now wearables are connecting everything else. With health data becoming increasingly more standardized and accessible, there is a future where healthcare is personalized not just to our health, but also to our l...
By Matt Balogh • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
E-Solutions as Part of a Multi-channel Strategy: An Integrated Approach to Reach the Physician
Integrated channel management offers an approach to combine e-solutions and traditional channels into a customized and cost-effective communications and optimization mix. With ever-increasing competition for healthcare providers’ time, attention, and the escalating challenge of access, the tradit...
By Peter Dussias • Nov. 15, 2014 -
Explore the Trendline➔
Stock via Getty Images
TrendlineOncology
As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Digital Solutions: A New Interface
We need to turn the discussion away from digital solutions, data strategy, or traditional channels and realize that it is all channels of interaction. The relationship between digital and traditional are not independent with one succeeding over another, but interdependent with both supporting the...
By Jeremy Shubert • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
2015 and beyond… This is the time of year when we all take a moment to reflect on the events of the past year and what lies ahead. In 2014, the industry went through a burst of deals between several major players — Novartis, Eli Lilly and Company, and GlaxoSmithKline — as they look to refocus on ...
By Taren Grom • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Bayer Helps Students Pursue Science Bayer Corp. presented a $100,000 two-year grant from the Bayer USA Foundation to Students 2 Science (S2S), an innovative STEM education organization that introduces elementary, middle, and high-school students from northern and central New Je...
By Denise Myshko • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
What's New
Ogilvy CommonHealth Worldwide Acquires Element Marketing Group TrendIng Now: Ogilvy CommonHealth extends focus on reimbursement and market share challenges. Ogilvy CommonHealth Worldwide, the health behavior experts of Ogilvy & Mather, has acquired Element Marketing Group (EMG), a market acce...
By Ann Grey • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Year in Preview: On the Horizon: Looking Ahead…
Experts from across all sectors of the industry provide their input on the trends in 2015 that will have the biggest impact on the industry, and how they will shape the future of healthcare. For this year’s special Year in Preview issue we took a slightly different tact than in years past. We are...
By Taren Grom • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotech Pool Dr. Annalisa Jenkins Dimension Therapeutics Names CEO Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, has apppointed Annalisa Jenkins, MBBS, MRCP, CEO. Dr. Jenkins succeeds interim CEO Thomas Beck. Dr. Jenkins brings to Dimensi...
By Ann Grey • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Electronic Health Record: A Focus On Patient Benefits
When we think of the positive impact of electronic health record (EHR) adoption, we often focus on the increased efficiency of the medical practice or additional convenience for healthcare providers (HCPs). We do not often associate those benefits with our most important target: the patient. Curr...
By Eugene Lee • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Embracing Co-Creation to Better Connect
Many patient and caregiver campaigns fail to resonate with their intended audiences. Innovative collaboration methods and co-creation with patients and caregivers can add authenticity to communications and elevate brands. Do you remember the telephone game when you were a kid? One person starts t...
By Dan Bobear • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Transdermal Delivery: Winning Patient Preference
The pharma landscape continues to be crowded and competitive, with more emphasis than ever before on delivering improved patient outcomes at a competitive price. In light of this, pharmaceutical companies must not only deliver products that effectively treat patients’ problems, but also prioritiz...
By Ingrid Blair • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Patient Solutions
As healthcare systems begin to pay for outcomes rather than products, patient-centric solutions and services will play a key role in the race to capture value. From wearables to improved drug delivery devices, from apps to EHR platforms, from patient trackers to packaging, the number of solution...
By Taren Grom • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Vested Outsourcing Imperative
Managing the Talent Supply Chain Large life sciences companies today face many challenges in acquiring and managing talent to meet their business imperatives. The first decision to be made is always the same, whether the workforce contains full-time employees, contingent workers, independent cont...
By Kevin D. Duffy • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Supply Chain: Talent Management: A Different Supply Chain Issue
A sound workforce strategy furthers a company’s business agenda and generates results. When the topic of supply chain management is discussed, the conversation typically is about manufacturing and distribution issues. But today one of the most pressing challenges facing CEOs is the talent supply ...
By Taren Grom • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Colombia Emerges as an Attractive Pharma Market
With a growing interest in attracting R&D and continual economic growth, Colombia is seen as an attractive market for pharmaceutical companies. The Republic of Colombia is evolving from an emerging economy, having enjoyed an economic turnaround since 2000, when it was perceived by economists ...
By Kim Ribbink • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Education of Principal Investigators
Efforts by pharma companies and other organizations aim to standardize GCP and training requirements for clinical research investigators and sites. Principal investigators and clinical sites are the backbone of clinical research. Sponsors and CROs depend on investigators and sites to conduct stud...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
New Models for Academic Partnerships
Academic medical centers have a renewed interest in partnering with pharmaceutical companies and are investing resources to ensure successful collaborations. Industry partnerships with universities are changing. These collaborations are no longer about single projects. They are broader in scope, ...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Nanomedicine Revolution
Nanomedicines have the potential to improve effectiveness and reduce the side effects of therapeutics. Nanotechnology has the potential to revolutionize healthcare across disciplines and specialties. For medicines specifically, nanotechnology can improve drug targeting and effectiveness and reduc...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool SCOTT HUNTER Shire Names Marketing Director of Ophthalmics Business Scott Hunter has been appointed as marketing director of the newly formed ophthalmics business at Shire. Mr. Hunter brings more than 12 years of eye care industry experience focused on therapies spanning ocular inflam...
By PharmaVoice Team • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D?Trends affecting the healthcare industry U.S. Pharmaceuticals Market is Improving Trending now: Patient access is broadening with implementation of the Affordable Care Act and the expansion of Medicaid. The outlook for the pharmaceutical market in the United States i...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-Based Applications, Sites, and Technologies IMS Health Introduces Cloud-Based Sales Solution Trending Now: New solution combines territory-specific intelligence, advanced performance analytics, and innovative mobility features. IMS Health has launched the U.S. version of Ne...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
What's New
Coalition Aims to Help Prevent Abuse and Diversion of ADHD medications Trending Now: Industry stakeholders band together to address medication misuse. The Coalition to Prevent ADHD Medication Misuse (CPAMM) was formed to prevent the misuse, abuse, and diversion of ADHD prescription stimulant medi...
By Ann Grey • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Reinvented Clinical Data Manager
A successful career in clinical data management is more rewarding — and more challenging — than ever before. Incumbents and those aspiring to the job must not only be technically proficient, but must also be strong communicators, project managers, and critical thinkers. While technological ad...
By Eboni Russell • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Digital Patients: Disrupting the Status Quo
Patients have the power of digital technology to fuel their quest for better health, which is forcing the industry to keep pace with their digital needs. Patients’ prolific use of digital technologies to improve their health outcomes is driving other healthcare stakeholders — physicians, payers, ...
By PharmaVoice Team • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool DR. JOHN ORLOFF Baxter Appoints VP of BioScience R&D Baxter International has appointed John Orloff, M.D., as VP and global head of research and development for Baxter BioScience. Dr. Orloff joins Baxter from Merck Serono Pharmaceuticals, where he served as global head of clinical...
By Ann Grey • Aug. 28, 2014
Previous
